AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $237,000 | +22.8% | 25,231 | 0.0% | 0.00% | – |
| Q2 2020 | $193,000 | +23.7% | 25,231 | 0.0% | 0.00% | – |
| Q1 2020 | $156,000 | -49.2% | 25,231 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $307,000 | +5.5% | 25,231 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $291,000 | +15.5% | 25,231 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $252,000 | -21.7% | 25,231 | +0.9% | 0.00% | 0.0% |
| Q1 2019 | $322,000 | -23.7% | 25,011 | -9.9% | 0.00% | 0.0% |
| Q4 2018 | $422,000 | -72.4% | 27,762 | -63.7% | 0.00% | -75.0% |
| Q3 2018 | $1,529,000 | +213.3% | 76,465 | +205.7% | 0.00% | +300.0% |
| Q2 2018 | $488,000 | -68.7% | 25,011 | -67.7% | 0.00% | -75.0% |
| Q1 2018 | $1,560,000 | +52.0% | 77,418 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $1,026,000 | +20.7% | 77,418 | +68.0% | 0.00% | +50.0% |
| Q3 2017 | $850,000 | +95.0% | 46,075 | +94.4% | 0.00% | +100.0% |
| Q2 2017 | $436,000 | -18.4% | 23,701 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $534,000 | -35.3% | 23,701 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $825,000 | +42.0% | 23,701 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $581,000 | +1.8% | 23,701 | -0.7% | 0.00% | 0.0% |
| Q2 2016 | $571,000 | +0.4% | 23,861 | -1.8% | 0.00% | 0.0% |
| Q1 2016 | $569,000 | -22.5% | 24,307 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $734,000 | -24.0% | 24,307 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $966,000 | -42.5% | 24,307 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $1,679,000 | +51.8% | 24,307 | +20.2% | 0.01% | +50.0% |
| Q1 2015 | $1,106,000 | -11.7% | 20,227 | -31.2% | 0.00% | 0.0% |
| Q4 2014 | $1,252,000 | +19.1% | 29,381 | -10.8% | 0.00% | +33.3% |
| Q3 2014 | $1,051,000 | +53.4% | 32,931 | -0.4% | 0.00% | +50.0% |
| Q2 2014 | $685,000 | +9.4% | 33,051 | +2.2% | 0.00% | 0.0% |
| Q1 2014 | $626,000 | -20.3% | 32,348 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $785,000 | +12.9% | 32,348 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $695,000 | -28.6% | 32,348 | -26.0% | 0.00% | -33.3% |
| Q2 2013 | $973,000 | – | 43,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |